Aorfix AAA Stent Graft Body with Aorflex Delivery System SG-HBB-24-81-80-14-A12-22Recalls & reported problems
Lombard Medical Limited · Aorflex AAA Stent Graft Body with Aorflex Delivery System · Class 3 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05055715606868), received between Mar 24, 2016 and Nov 23, 2016 — classified as 2 injuries.
The most frequently reported specific device problem is “Positioning Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Positioning Problem1
Patient problems
- Aneurysm2
- Occlusion2
- Ischemia1
- Thrombus1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryNov 23, 2016Positioning Problem; Positioning Problem
ORIGINAL EVAR WAS PERFORMED ON (B)(6) 2016. THE PHYSICIAN PLACED THE MAIN BODY STENT GRAFT FROM THE LEFT FEMORAL ARTERY APPROACH AND A CONTRALATERAL LEG FROM THE RIGHT APPROACH. PRIOR TO COMPLETION OF THE PROCEDURE, THE PHYSICIAN HAD CONFIRMED THAT A PRESSURE GAP WAS PRESENT BETWEEN THE RIGHT AND LEFT LEGS. BECAUSE THE LEFT LEG PRESSURE WAS LOWER, THE PHYSICIAN RE-INFLATED A BALLOON CATHETER IN THE IPSILATERAL LIMB IN ORDER TO ADJUST IT. EVEN THOUGH A SLIGHT PRESSURE GAP WAS STILL PRESENT AT THAT TIME, THE PHYSICIAN DECIDED THAT IT WAS ACCEPTABLE AND FINISHED THE PROCEDURE. THE FINAL ANGIOGRAPHY REVEALED A PATENCY OF THE STENT GRAFT. THE PATIENT WAS DISCHARGED FROM HOSPITAL ON (B)(6) 2016, HOWEVER THE NEXT DAY THE PATIENT REPORTED A PAIN IN THE LEFT LEG. CT IMAGING PERFORMED ON (B)(6) 2016 REVEALED THROMBUS IN THE IPSILATERAL LIMB. BLOOD FLOW INTO THE DISTAL PORTION WAS SECURED FROM ANOTHER VESSEL. THE CT IMAGE REVEALED AN OCCLUSION OF THE PROXIMAL PORTION OF THE IPSILATERAL LIMB. THE PHYSICIAN CARRIED OUT A RE-INTERVENTION WHERE A SURGICAL THROMBECTOMY WAS PERFORMED WITH A FOGARTY BALLOON CATHETER, PLACING A BALLOON EXPANDABLE STENT (10MM X 3CM, ASSURANT COBALT, MEDTRONIC) AT THE
Patient problems: Aneurysm; Occlusion; Thrombus
MAUDE report 6124514 ↗InjuryMar 24, 2016Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
EVAR WAS PERFORMED (B)(6) 2016. LEFT RENAL ARTERY OCCLUSION. TYPE 1A ENDOLEAK. THE PROCEDURE WAS PERFORMED BY PLACING A MAIN BODY FROM THE LEFT APPROACH FOLLOWING THE IFU. THE PHYSICIAN ATTEMPTED TO LOWER AND DEPLOY THE MAIN BODY BY ADJUSTING FROM A PORTION 1 CM UPPER FROM THE LEFT RENAL ARTERY. AT A STAGE WHERE HE DEPLOYED IT TO THE CONTRA-LATERAL SOCKET, HE RELEASED A SUPPORT TUBE, PERFORMED A CANNULATION ON THE CONTRA-LATERAL LEG AND INFLATED A BALLOON CATHETER IN THE PROXIMAL PART FROM THE CONTRA-LATERAL SIDE. AFTER DEPLOYING AN IPSI-LATERAL LIMB, HE PLACED A CONTRA-LATERAL LIMB. AFTER INFLATING A BALLOON CATHETER THROUGHOUT THE WHOLE DEVICE, A FINAL ANGIOGRAPHY REVEALED NO IMAGE OF THE LEFT RENAL ARTERY AND A TYPE 1A ENDOLEAK. REGARDING THE EVENT 1, BY TAKING AN ACCESS FROM THE LEFT BRACHIAL ARTERY, HE ATTEMPTED TO ADVANCE A GUIDE WIRE FROM THE UPPER SIDE TOWARD THE LEFT RENAL ARTERY, BUT HE HAD A DIFFICULTY IN CANNULATION. THEN, HE CONCLUDED IT WAS IMPOSSIBLE TO PERFORM THE CANNULATION. REGARDING THE EVENT 2, BY ADDITIONALLY PLACING A PROXIMAL EXTENDER, THE TYPE 1A ENDOLEAK WAS RESOLVED. THE PROCEDURE WAS FINISHED WITH THE LEFT RENAL ARTERY OCCLUSION REMAINING. UPDATE RECEIVE
Patient problems: Aneurysm; Ischemia; Occlusion
MAUDE report 5522538 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page